Oorsprong van het eerstegraads netwerk van Maria Castresana
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
16
| Public Company | Biotechnology | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Maria Castresana via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | ||
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Mutual of New York Life /2 Hampton Inns/ | Hotels/Resorts/Cruise lines | Corporate Officer/Principal | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Investment Managers | Private Equity Investor | |
Fresenius ProServe GmbH
 Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Hospital/Nursing Management | Chief Executive Officer | |
| University of California, Irvine | College/University | Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University College London | College/University | Doctorate Degree | |
| University of Münster | College/University | Undergraduate Degree | |
| Eberhard Karls Universität Tübingen | College/University | Graduate Degree | |
| University of Zurich | College/University | Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| Humboldt-Universität zu Berlin | College/University | Graduate Degree | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Director/Board Member | |
| BIONTECH SE | Biotechnology | Director of Finance/CFO | |
Amgen NV
 Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the private company is Gabor Sztaniszlav. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Austria GmbH
 Novartis Austria GmbH Pharmaceuticals: MajorHealth Technology Novartis Austria GmbH operates as a holding company, which engages in the development and production of pharmaceutical products. The company was founded on January 30, 2006 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hospitalia International GmbH
 Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The private company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Medical/Nursing Services | Corporate Officer/Principal | |
Fresenius Kabi Asia Pacific Ltd.
 Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Medical Distributors | Corporate Officer/Principal | |
| Duale Hochschule Baden-Württemberg Mannheim | College/University | Undergraduate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director of Finance/CFO | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director/Board Member | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Boys & Girls Clubs of Metro Los Angeles is a non-profit organization that was founded in December 2015 to provide a sustainable solution to the opportunity crises facing vulnerable children in the neediest neighborhoods of Los Angeles. Boys & Girls Clubs of Metro Los Angeles is based in Los Angeles, CA, and has subsidiaries in the United States. The organization operates four clubs in Bell Gardens, Challengers, Downs, and Willowbrook, and offers nationally recognized, research-based programs and activities in three core areas: academic success, good character and citizenship, and healthy lifestyles. The organization empowers youth to explore a future with endless possibilities by offering creative programming, such as new approaches to science, technology, engineering, and math (STEM) created in collaboration with community partners. The non-profit company was founded in 2015, and the CEO is Patrick Mahoney. | Miscellaneous Commercial Services | Director/Board Member | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Hospitalia Care Gmbh | Corporate Officer/Principal | ||
Fresenius Kabi Deutschland GmbH
 Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The private company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Pharmaceuticals: Generic | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 22 |
| Duitsland | 21 |
| Zwitserland | 5 |
| Verenigd Koninkrijk | 3 |
| België | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 15 |
| Health Services | 4 |
| Finance | 3 |
| Distribution Services | 2 |
Operationeel
| Corporate Officer/Principal | 35 |
| Director/Board Member | 29 |
| Chief Tech/Sci/R&D Officer | 12 |
| Independent Dir/Board Member | 10 |
| Chief Executive Officer | 9 |
Sterkste connecties
| Insiders | |
|---|---|
| Wendy Johnson | 23 |
| Frank Morich | 21 |
| Jens Holstein | 14 |
| Malte Peters | 11 |
| Andrew Cheng | 10 |
| Sung Lee | 6 |
| Tim Demuth | 5 |
| Thomas Biegi | 4 |
| Katharina Kreymborg | 4 |
| Markus Enzelberger | 3 |
| Lucinda Crabtree | 3 |
| Roland Wandeler | 3 |
| Luisa Ciccarelli | 3 |
| Daniel Palmacci | 2 |
| Robert Mayer | 1 |
- Beurs
- Insiders
- Maria Castresana
- Bedrijfsconnecties
